RHRobin H. Heijmen

Robin H. Heijmen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robin H. Heijmen has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    254 * LEFT SUBCLAVIAN ARTERY REVASCULARIZATION AS PART OF THORACIC ENDOVASCULAR AORTIC REPAIR

    by N. Saouti, W. J. Morshuis, R. H. Heijmen

    Objectives: Intentionally covering the left subclavian artery (LSA) as part of thoracic endovascular aortic repair (TEVAR) can cause (posterior) strokes or left arm malperfusion. LSA revascularization can be done prophylactically for, or as treatment of, these complications. We report our experience with the surgical technique, indications, and the results of LSA revascularization. Methods: Between 2000 and 2013, 53 patients out of 444 treated by TEVAR, had LSA revascularization. All elective patients had a preoperative work-up with magnetic resonance angiogram to evaluate the circle of Willis. In all, surgical access was through a left supraclavicular incision only. Results: The majority (87%) had prophylactic LSA revascularization because of incomplete circle of Willis and/or left dominant vertebral artery (LVA) (n = 40), patent left internal mammary artery (n = 2), prevention of myelum ischaemia (n = 2), prevention of left arm ischaemia due to small LVA (n = 2) and LVA origin in arch (n = 1). Thirteen per cent had secondary revascularization, either immediate because of malperfusion of the left arm (n = 2), or late after TEVAR because of persisting left arm claudication (n = 4). In nine patients, the following early complications were observed: re-exploration for bleeding, n = 1; left recurrent nerve paralysis, n = 2; left phrenic nerve paralysis, n = 2; left sympathetic chain neuropraxia, resulting in Horner's syndrome, n = 3; chyle duct lesions, resulting in persistent chyle leakage, n = 3. No strokes were observed. One patient experienced occlusion of the bypass at six months. Conclusions: The present study shows that the procedure of LSA revascularization as part of TEVAR is feasible and safe with low morbidity and negligible risk of strokes.

  • Endovascular Treatment of Ruptured Thoracic Aortic Aneurysm in Patients Older than 75 Years

    by F.H.W. Jonker, H.J.M. Verhagen, R.H. Heijmen, P.H. Lin, S. Trimarchi, W.A. Lee, F.L. Moll, H. Athamneh, B.E. Muhs

  • Thoracoabdominal Aortic Aneurysm Repair: Results of Conventional Open Surgery

    by M.A. Schepens, R.H. Heijmen, W. Ranschaert, U. Sonker, W.J. Morshuis

    • 2 November 2002
      • Vol. 146  (44) , 2087-92

    [Pulmonary thromboendarterectomy: an effective surgical treatment for cor pulmonale due to chronic pulmonary emboli].

    by R H Heijmen, S W Van Haarlem, W J Morshuis, E W Jansen, W Jaarsma, R J Snijder

    To evaluate the initial experience with pulmonary thromboendarterectomy for cor pulmonale due to chronic pulmonary embolism. In the period 1 April 1996 to 31 October 2001, 18 patients with right ventricular failure due to chronic thromboembolic pulmonary hypertension were operated on. Their mean age was 54 (SD: 14) years. Preoperatively, all of the patients were in functional New York Heart Association (NYHA) class III or IV. Pulmonary angiography revealed pulmonary hypertension with an increased pulmonary vascular resistance, as well as typical angiographic signs of unresolved chronic emboli. Pulmonary thromboendarterectomy was performed via median sternotomy, using extracorporeal circulation and intermittent deep hypothermic circulatory arrest. The patients were monitored via the outpatients' department. From a technical viewpoint, the procedure was performed successfully in all of the patients. Initially the pulmonary thromboendarterectomy was performed unilaterally (n = 7), which did not decrease pulmonary artery pressure significantly. The following 11 patients were treated bilaterally; in them thromboendarterectomy required an average of circulatory arrest totalling 64 (SD: 30) min with 161 (SD: 35) min of myocardial ischemia. After bilateral pulmonary thromboendarterectomy, the pulmonary artery pressure decreased from 45 (SD: 13) to 28 (SD: 9) mmHg (p = 0.001). Reperfusion pulmonary oedema, requiring prolonged ventilation, occurred in 3 patients. There was no operative or later mortality. At a mean follow-up of 28 (SD: 19) months, all but one of the patients were in functional NYHA class I or II. Echocardiography revealed reduced right ventricular dimensions and pulmonary artery pressures. One patient, with mainly distally located obstructions, exhibited no substantial improvement. The initial experience with pulmonary thromboendarterectomy for patients with cor pulmonale due to chronic pulmonary emboli demonstrated satisfactory mid-term follow-up data.

  • Open Access

    Mural thrombosis in thoracic aortic stent-graft.

    by Robin H. Heijmen, Marc A.A.M. Schepens

    Routine computed tomography (CT) scanning, 1 year after endovascular treatment of a saccular, descending thoracic aortic aneurysm with an Excluder stent-graft (internally covered with polytetrafluoroethylene (PTFE)) (Fig. 1) , revealed intraluminal thrombus formation along its length and circumference (Fig. 2A,B) , despite antiplatelet therapy (acetylsalicylic acid). No hereditary coagulation disorder is known in this patient. Although previously described in abdominal bifurcated stent-grafts, it is an unreported finding in the thoracic aorta.


  • Endovascular stent-grafting for descending thoracic aortic aneurysms

    by R Heijmen

    Endoluminal placement of covered stent-grafts emerges as a less-invasive alternative to open surgical repair of thoracic aortic aneurysms (TAA). The present report describes our experience with endovascular stent-grafting in the treatment of descending TAA. From 1997 to 2001, 28 descending TAA's were treated in 27 patients (17 male, mean age 70 years) by endovascular stent-grafting. The aneurysms (mean diameter, 6.6 cm) had diverse causes, but the majority were due to atherosclerosis (71%). They were predominantly localized in the proximal (32%), central (39%), and distal part (22%) of the descending thoracic aorta. In two patients (7%), the entire thoracic aorta was treated. Preliminary subclavian-carotid artery transposition was performed in five patients. AneurX (n=6), Talent (n=9), and Excluder (n=13) stent-grafts were used. In 13 cases (46%), multiple stents were necessary for complete aneurysm exclusion. In 27 of 28 cases (96%), the endovascular stent-grafts were successfully deployed. In one patient, stent dislocation into the aneurysm required open surgical repair in a subsequent procedure. There was no operative mortality. None of the patients developed paraplegia or paraparesis. No distal embolization occurred. After a median follow-up of 21 months (range, 1-49 months), there was one non-related late death. There was no aneurysm rupture. Maximal aneurysm diameter either remained stable or decreased slightly over time in all but one patient with evidence of an endoleak. Endoleaks occurred in eight patients (29%) during follow-up. In five of them the endoleaks sealed spontaneously, whereas in two patients a distal extension was inserted. Endovascular repair of descending TAA's is a promising less-invasive alternative to open repair. Extended follow-up is necessary to determine its definite efficacy in the longer term.


  • Use of a Balloon-Expandable, Radially Reinforced ePTFE Endograft after Remote SFA Endarterectomy: A Single-Center Experience

    by Robin H. Heijmen, Joep A.W. Teijink, Jos C. van Den Berg, Tim Th.C. Overtoom, Gerard Pasterkamp, Frans L. Moll

    Purpose: To report our experience with endovascular femoropopliteal bypass grafting using a distensible, radially reinforced polytetrafluoroethylene endograft combined with remote endarterectomy. Methods: Forty-one patients (33 men; mean age 70 years, range 45–79) with symptomatic femoropopliteal occlusive disease underwent remote endarterectomy of the superficial femoral artery (SFA) followed by implantation of a balloon-expandable Enduring endovascular graft. All patients entered an extensive surveillance program, including angiography and duplex scanning at regular intervals. Results: Endarterectomy and endograft implantation were ultimately successful in all patients; 5 (12%) technical difficulties occurred intraoperatively and were treated with additional endovascular techniques. Control angiography at 1 week postoperatively demonstrated a patent endograft in 39 (95%) patients. Mean ankle-brachial index increased significantly from 0.57 to 0.91 (p < 0.001). Including the 2 early failures, 18 occlusions were documented over a median 15-month follow-up (range 3–24), due mainly to significant stenosis at the proximal and distal anastomoses. In 8 of 10 successfully reopened and revised endografts, reocclusion occurred after a median interval of only 1.8 months. Life-table analysis revealed cumulative primary and secondary patency rates of 42% and 56%, respectively, at 18 months. In the last 12 cases, the proximal end of the graft was sutured end-to-end to the transected SFA, which improved the short-term secondary patency rate to 83%. Conclusions: Insertion of the Enduring endovascular graft following remote endarterectomy effectively results in a less invasive treatment for femoropopliteal occlusive disease. Additional technical refinements of the procedure may be required to avoid early procedure-and graft-related failures.


    • 1 February 2001
      • Vol. 42  (1) , 83-7

    Endovascular venous stenting in May-Thurner syndrome.

    by R H Heijmen, T L Bollen, D A Duyndam, T T Overtoom, J C Van Den Berg, F L Moll

    Chronic pulsatile compression of the left common iliac vein between the crossing right common iliac artery and the lowest lumbar vertebral body may induce focal intimal proliferation of the vein (May-Thurner syndrome), resulting in impaired venous return and left iliofemoral thrombosis. Corrective surgical treatment requires extensive dissection. In this report, we describe our experience with endovascular venous stenting in May-Thurner syndrome. Six patients with symptomatic May-Thurner syndrome were treated with percutaneous transluminal angioplasty and implantation of self-expanding stents. RESULTS Postprocedure phlebography revealed patent iliofemoral veins with unimpeded venous outflow and disappearance of collaterals in all patients. No procedure-related complications occurred. At follow-up (median, 12 months), 5 of 6 patients were free of symptoms. In one patient lower extremity edema was aggravated despite a patent stented segment of the left iliac vein. The patient continues to wear support stockings to compensate for continuing venous insufficiency. Color coded duplex scanning revealed patency at regular intervals in 5 patients. In one patient, occlusion of the stented venous segment with return of symptoms was detected at one month. Patency could not be restored despite catheter-directed thrombolytic therapy. After angioplasty, however, adequate collateral circulation was restored and symptoms resolved completely. Endovascular venous stenting in May-Thurner syndrome is technically feasible, and leads to reduction of symptoms in the majority of patients with high patency rates in the medium-term. This approach may prove to be a percutaneous alternative to surgical treatment.